This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
这位globant分析师不再看好;以下是本周二的前5大降级
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
华尔街顶级分析师改变了对这些顶级公司的展望。如需查看包括升级和降级在内的所有分析师评级变化的完整视图,请参阅我们的分析师评级页面。
- UBS analyst Leonardo Olmos downgraded the rating for Globant S.A. (NYSE:GLOB) from Buy to Neutral, while raised the price target from $225 to $235. Globant shares fell 1.1% to close at $201.98 on Monday. See how other analysts view this stock.
- Citigroup analyst Thomas Singlehurst downgraded Stride, Inc. (NYSE:LRN) from Buy to Neutral, but increased the price target from $77 to $90. Stride shares gained 1.5% to close at $83.77 on Monday. See how other analysts view this stock.
- JP Morgan analyst Tien-Tsin Huang downgraded the rating for AvidXchange Holdings, Inc. (NASDAQ:AVDX) from Overweight to Neutral and lowered the price target from $11 to $9. AvidXchange shares gained 1.4% to close at $8.24 on Monday. See how other analysts view this stock.
- JMP Securities analyst Nicholas Jones downgraded PropertyGuru Group Limited (NYSE:PGRU) from Market Outperform to Market Perform. PropertyGuru shares settled at $6.55 on Monday. See how other analysts view this stock.
- Benchmark analyst Robert Wasserman downgraded the rating for AbCellera Biologics Inc. (NASDAQ:ABCL) from Buy to Hold. AbCellera Biologics shares gained 3.8% to close at $2.71 on Monday. See how other analysts view this stock. See how other analysts view this stock.
- 瑞银分析师Leonardo Olmos将Globant S.A. (NYSE: GLOB)评级由买入下调至中立,但将价值目标从225美元提高到235美元。周一,Globant股票下跌1.1%,收于201.98美元。查看其他分析师对该股票的看法。
- 花旗集团分析师Thomas Singlehurst将Stride,Inc. (NYSE: LRN)的评级由买入下调至中立,但将价值目标从77美元增加至90美元。周一,Stride股票上涨1.5%,收于83.77美元。查看其他分析师对该股票的看法。
- 摩根大通分析师Tien-Tsin Huang将AvidXchange Holdings, Inc. (NASDAQ: AVDX)的评级由超重下调至中立,并将价值目标从11美元下调至9美元。周一,AvidXchange股票上涨1.4%,收于8.24美元。查看其他分析师对该股票的看法。
- JMP Securities分析师Nicholas Jones将PropertyGuru Group Limited (NYSE: PGRU)的评级从市场跑赢降至市场表现。周一,PropertyGuru股票定居于6.55美元。查看其他分析师对该股票的看法。
- Benchmark分析师Robert Wasserman将AbCellera Biologics Inc. (NASDAQ: ABCL)的评级从买入下调至持有。周一,AbCellera Biologics股票上涨3.8%,收于2.71美元。查看其他分析师对该股票的看法。查看其他分析师对该股票的看法。
Considering buying GLOB stock? Here's what analysts think:
考虑买Globant股票?以下是分析师的看法:
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240820/0-960f92a2bb77a34c46ae06e3dc1b4e1c-0-cf309e7e4e7e0678571927681cc38b26.png/big)
- S&P 500, Nasdaq Extend Gains For 8th Consecutive Session: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone
- 标普500指数和纳斯达克指数连续第8个交易日上涨:投资者情绪好转,但贪婪指数仍处于“恐惧”区域。